Drug Approval News, In Brief
Executive Summary
FDA’s recent actions include approval for Horizon’s Rayos delayed-release prednisone and “complete response” letters for two other drugs – Otsuka/Lundbeck’s depot injection of the atypical antipsychotic aripiprazole and Luitpold’s iron deficiency anemia treatment Injectafer.